BIOGEN INC. is 25.9x more valuable than DBV Technologies S.A. by market capitalization ($28.73 B vs $1.11 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | DBVT | BIIB |
|---|---|---|
| Market cap | $1.11 B | $28.73 B |
| US-listed rank | #2563 | #479 |
| Revenue (latest FY) | $5.64M | $9.89B |
| Net income (latest FY) | -$146.95M | $1.29B |
| Net margin | -2607.3% | 13.1% |
| P/E (trailing FY) | - | 22.2 |
| SEC filings | 563 | 2,690 |
BIOGEN INC. is 25.9x more valuable than DBV Technologies S.A. by market capitalization ($28.73 B vs $1.11 B).
In their latest fiscal years, DBV Technologies S.A. reported $5.64M in revenue while BIOGEN INC. reported $9.89B.
Full pages: DBV Technologies S.A. and BIOGEN INC., or browse the full rankings.